Earnings History Data for Nevro Corp. (NVRO) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Nevro Corp.

Nevro Corp. is a medical device company. It engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain. The Company provides pain relief to the customers suffering from low back pain and types of chronic pains. Nevro has developed and commercialized the Senza (R) spinal cord stimulation (SCS) system for the treatment of chronic pain. Senza, HF10, Nevro and the Nevro logo are trademarks of the company. Nevro Corp. is headquartered in Menlo Park, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
11-11-2024	AH		NVRO	Nevro Corp.	199.09	-0.51	-0.82	-0.65	Nevro GAAP EPS of -$0.41 beats by $0.40, revenue of $96.91M beats by $3.91M [11/11/2024 4:24 PM]	5.04	-0.28 (-5.17%)	6.68	1.36 (25.56%)	4.38 - 22.64	1,808,968	650,000	51,786
Nevro GAAP EPS of -$0.41 beats by $0.40, revenue of $96.91M beats by $3.91M [11/11/2024 4:24 PM] Nevro: Q3 Earnings Snapshot [2024-11-11 04:15PM] Nevro Reports Third-Quarter 2024 Financial Results [2024-11-11 04:05PM] Nevro Corp (NVRO) Q3 2024 Earnings Report Preview: What To Expect [Nov-08-24 07:05AM] Nevro (NVRO) Reports Q3 Loss, Tops Revenue Estimates [Nov-11-24 05:20PM]
06-08-2024	AH		NVRO	Nevro Corp.	337.17	-0.43	-0.63	-0.69	Nevro reports mixed Q2 results; initiates Q3 and updates FY24 outlook [8/6/2024 5:47 PM]	4.88	-3.80 (-43.79%)	5.48	-3.21 (-36.94%)	4.38 - 22.64	4,569,040	510,000	78,310
Nevro reports mixed Q2 results; initiates Q3 and updates FY24 outlook [8/6/2024 5:47 PM] Nevro plunges as revised guidance draws downgrades [8/7/2024 2:59 PM]
07-05-2024	AH		NVRO	Nevro	409.00	-0.70	-1.02	0.00	Nevro GAAP EPS of -$0.70 beats by $0.35, revenue of $101.9M beats by $3.97M [5/7/2024 4:24 PM]	10.15	-1.38 (-11.97%)	12.00	0.47 (4.08%)	10.06 - 28.89	752,206	670,000	40,536
Nevro GAAP EPS of -$0.70 beats by $0.35, revenue of $101.9M beats by $3.97M [5/7/2024 4:24 PM]
21-02-2024	AH		NVRO	Nevro Corp.	627.08	-0.15	-0.50	-0.54	Nevro GAAP EPS of -$0.25 beats by $0.24, revenue of $116.17M beats by $0.17M [2/21/2024 4:28 PM]	16.39	-0.20 (-1.21%)	17.17	0.58 (3.50%)	13.98 - 39.67	1,021,446	360,000	813
Nevro GAAP EPS of -$0.25 beats by $0.24, revenue of $116.17M beats by $0.17M [2/21/2024 4:28 PM] Oppenheimer cuts Nevro to perform, cites weakness in core business [2/22/2024 12:59 PM]
01-11-2023	AH		NVRO	Nevro Corp.	512.18	-0.65	-0.77	-0.62	Nevro GAAP EPS of -$0.65 beats by $0.12, revenue of $103.9M beats by $8.02M [11/1/2023 4:23 PM]	14.97	0.37 (2.53%)	14.97	0.0 (0.00%)	13.98 - 48.10	2,009,328	570,000	13,129
Nevro GAAP EPS of -$0.65 beats by $0.12, revenue of $103.9M beats by $8.02M [11/1/2023 4:23 PM]
01-08-2023	AH		NVRO	Nevro Corp.	875.01	-0.69	-0.68	-0.71	Nevro GAAP EPS of -$0.69 in-line, revenue of $108.8M beats by $0.74M [8/1/2023 4:33 PM]	20.05	-4.62 (-18.73%)	22.56	-2.11 (-8.55%)	18.44 - 53.34	2,131,468	450,000	17,601
Nevro GAAP EPS of -$0.69 in-line, revenue of $108.8M beats by $0.74M [8/1/2023 4:33 PM]
26-04-2023	AH	4:05 PM ET (Apr 26)	NVRO	Nevro Corp.	1,210	-0.98	-1.06	-0.98	Nevro beats Q1 top and bottom line estimates; initiates Q2 and reaffirms FY23 outlook [4/26/2023 4:48 PM]	30.31	-4.28 (-12.37%)	34.59	0.0 (0.00%)	28.75 - 67.59	746,742	850,000	26,902
Nevro beats Q1 top and bottom line estimates; initiates Q2 and reaffirms FY23 outlook [4/26/2023 4:48 PM]
16-02-2023	AH	4:05 PM ET (Feb 16)	NVRO	Nevro Corp.	1,300	-0.54	-0.49	-0.86	Nevro GAAP EPS of -$0.54 misses by $0.05, revenue of $113.84M beats by $0.14M [2/16/2023 4:22 PM]	35.94	-3.57 (-9.04%)	37.54	-1.97 (-4.99%)	34.70 - 78.90	847,373	600,000	428
Nevro GAAP EPS of -$0.54 misses by $0.05, revenue of $113.84M beats by $0.14M [2/16/2023 4:22 PM]
02-11-2022	AH	4:05 PM ET (Nov 2)	NVRO	Nevro Corp.	1,360	-0.62	-0.71	-0.87	Nevro GAAP EPS of $2.22 beats by $2.32, revenue of $100.5M beats by $1.34M [11/2/2022 4:37 PM]	41.67	4.97 (13.56%)	36.70	0.0 (0.00%)	34.70 - 115.82	1,620,198	910,000	10,008
Nevro GAAP EPS of $2.22 beats by $2.32, revenue of $100.5M beats by $1.34M [11/2/2022 4:37 PM] Nevro Reports Third Quarter 2022 Financial Results, Narrows Full-Year 2022 Guidance and Raises Revenue Contribution from Painful Diabetic Neuropathy [Nov-02-22 04:05PM]
03-08-2022	AH	4:05 PM ET (Aug 3)	NVRO	Nevro Corp.	1,560	-0.71	-0.81	-0.62	Nevro Q2 results mixed, co cuts FY 2022 revenue guidance, sees wider FY adj. EBITDA loss [8/3/2022 4:30 PM]	45.58	-1.84 (-3.89%)	3.92	-0.40 (-9.26%)	39.41 - 152.09	1,190,314	450,000	51,552
Nevro Q2 results mixed, co cuts FY 2022 revenue guidance, sees wider FY adj. EBITDA loss [8/3/2022 4:30 PM]
04-05-2022	AH	4:05 PM ET (May 4)	NVRO	Nevro	2,171	-0.98	-1.11	0.00	Nevro GAAP EPS of -$0.98 beats by $0.12, revenue of $87.84M beats by $1.65M [5/4/2022 4:40 PM]	55.58	-7.29 (-11.60%)	64.57	1.70 (2.70%)	55.22 - 182.45	1,473,947	430,000	100
Nevro GAAP EPS of -$0.98 beats by $0.12, revenue of $87.84M beats by $1.65M [5/4/2022 4:40 PM] Further weakness as Nevro (NYSE:NVRO) drops 6.8% this week, taking one-year losses to 62% [May-04-22 09:03AM] Nevro Reports First Quarter 2022 Financial Results, Provides Second Quarter 2022 Guidance and Reiterates Full-Year 2022 Guidance [May-04-22 04:05PM] Nevro (NVRO) Reports Q1 Loss, Tops Revenue Estimates [May-04-22 06:25PM]
23-02-2022	AH	4:05 PM ET (Feb 23)	NVRO	Nevro Corp.	2,270	-0.86	-0.86	-0.21	Nevro GAAP EPS of -$0.86 in-line, revenue of $102.76M beats by $2.06M [2/23/2022 4:23 PM]	66.63	-2.96 (0.00%)	63.50	-0.93 (-1.44%)	66.25 - 183.77	1,109,641	646,198	14,857
Nevro GAAP EPS of -$0.86 in-line, revenue of $102.76M beats by $2.06M [2/23/2022 4:23 PM] Nevro Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides First Quarter and Full-Year 2022 Guidance [Feb-23-22 04:05PM] Nevro (NVRO) Reports Q4 Loss, Tops Revenue Estimates [Feb-23-22 06:15PM] Nevro's (NVRO) Q4 Earnings in Line, Revenues Beat Estimates [Feb-24-22 01:02PM]
08-11-2021	AH	4:05 PM ET (Nov 8)	NVRO	Nevro Corp.	3,830	-0.87	-0.86	-0.29	Nevro EPS misses by $0.57, beats on revenue [11/8/2021 4:29 PM]	105.00	-3.94 (-3.62%)	99.00	-9.94 (-9.12%)	98.22 - 188.14	1,603,839	460,000	6,395
Nevro EPS misses by $0.57, beats on revenue [11/8/2021 4:29 PM] Truist downgrades Nevro to hold on recovery in spinal cord stimulation market [11/9/2021 12:53 PM] Nevro Reports Third Quarter 2021 Financial Results and Provides Fourth Quarter Guidance [Nov-08-21 04:05PM] Nevro (NVRO) Reports Q3 Loss, Tops Revenue Estimates [Nov-08-21 05:45PM] Nevro Corp (NVRO) Q3 2021 Earnings Call Transcript [Nov-09-21 02:30AM] Nevro (NVRO) Q3 Earnings Miss Estimates, Revenues Surpass [Nov-09-21 07:32AM] Heres What Prompted Carillon Tower to Liquidate its Nevro Corp. (NVRO) Position [Nov-09-21 11:15AM]
04-08-2021	AH	4:05 PM ET (Aug 4)	NVRO	Nevro Corp.	5,390	-0.62	-0.71	-1.21	Nevro EPS beats by $0.11, misses on revenue; Q3 revenue guidance below consensus [8/4/2021 4:37 PM]	115.01	-32.87 (-22.23%)	110.50	-37.38 (-25.28%)	106.75 - 188.14	5,039,641	310,000	108,028
Nevro EPS beats by $0.11, misses on revenue; Q3 revenue guidance below consensus [8/4/2021 4:37 PM] Nevro down 26% on Q2 results, pulling 2021 guidance, and analyst cuts [8/5/2021 12:37 PM] Nevro Reports Second Quarter 2021 Financial Results and Provides Third Quarter of 2021 Guidance [Aug-04-21 04:05PM] Nevro (NVRO) Reports Q2 Loss, Misses Revenue Estimates [Aug-04-21 06:25PM] Nevro Corp (NVRO) Q2 2021 Earnings Call Transcript [Aug-05-21 04:01AM] Is Nevro (NYSE:NVRO) Using Too Much Debt? [Aug-05-21 06:35AM] Why Nevro Is Falling So Hard Today [Aug-05-21 04:14PM]
05-05-2021	AH	4:05 PM ET (May 5)	NVRO	Nevro Corp.	6,000	-0.85	-0.86	-0.78	Nevro reports Q1 results [5/5/2021 4:32 PM]	156.58	-4.81 (-2.98%)	156.58	0.0 (0.00%)	111.87 - 188.14	831,613	660,000	3,490
Nevro Corp. to Host Earnings Call [May-05-21 02:30PM] Nevro Reports First Quarter 2021 Financial Results and Updates 2021 Guidance [May-05-21 04:05PM] Nevro (NVRO) Reports Q1 Loss, Tops Revenue Estimates [May-05-21 06:15PM] Nevro Corp (NVRO) Q1 2021 Earnings Call Transcript [May-06-21 01:31AM]
24-02-2021	AH	4:00 PM ET (Feb 24)	NVRO	Nevro Corp.	5,790	-0.21	-0.35	-0.44	Nevro EPS beats by $0.13, beats on revenue [2/24/2021 4:24 PM]	167.68	-3.23 (-1.89%)	165.00	-5.91 (-3.46%)	65.05 - 188.14	540,699	321,519	409
Nevro EPS beats by $0.13, beats on revenue [2/24/2021 4:24 PM] Nevro Corp (NVRO) Q4 2020 Earnings Call Transcript [Feb-24-21 09:00PM] Recap: Nevro Q4 Earnings [Feb-24-21 05:01PM] Nevro Reports Fourth Quarter and Full Year 2020 Financial Results [Feb-24-21 04:05PM] Nevro Corp. to Host Earnings Call [Feb-24-21 02:30PM]
05-11-2020	AH	4:10 PM ET (Nov 5)	NVRO	Nevro Corp.	5,140	-0.29	-0.59	-0.58	Nevro EPS beats by $0.30, beats on revenue [11/5/2020 4:40 PM]	160.41	2.34 (1.48%)	145.00	-13.07 (-8.27%)	65.05 - 169.09	388,470	290,848	4,696

05-08-2020	AH	4:10 PM ET (Aug 5)	NVRO	Nevro Corp.	4,520	-1.21	-1.65	-0.91	Nevro EPS beats by $0.43, beats on revenue [8/5/2020 4:22 PM]	141.26	3.97 (2.89%)	137.29	0.0 (0.00%)	60.85 - 148.05	324,677	266,334	4,456

05-05-2020	AH	4:10 PM ET (May 5)	NVRO	Nevro Corp.	3,760	-0.78	-0.98	-1.45	Nevro EPS beats by $0.17, beats on revenue [5/5/2020 4:18 PM]	118.49	5.90 (5.24%)	0.0	0.0 (0.00%)	54.00 - 148.05	487,693	395,033	0